PSYC Welcomes Key Additions to Leadership Team
April 11 2022 - 8:30AM
InvestorsHub NewsWire
PSYC Welcomes Key Additions to
Leadership Team
LAKE OSWEGO, OR -- April 11, 2022 --
InvestorsHub NewsWire -- PSYC Corporation
(OTCPink:
PSYC) (“PSYC” or the “Company”) a media leader for the emerging
sector of medicinal psychedelics and authorities behind Psychedelic Spotlight, a top ranking psychedelic news
and information platform, is pleased to welcome Sacha G. Hebbert,
Robin Divine, and Brad Schlesinger, Esq. to the leadership team for
its wholly owned subsidiary, Spotlight Media Corporation, and
rapidly expanding Psychedelic Spotlight media
platform.
Ms. Hebbert joins PSYC as a seasoned Executive Sales
and Marketing Consultant, bringing with her over ten years of
Content Marketing and Management experience, including roles as
Sales Operations Manager for PharmaDrug Inc. and Senior Product and
Marketing Manager for Mindcure
Health.
As one of the most recognized media platforms for the
growing community of psychedelics, the Company expects Ms. Hebbert
to play an integral role in refining its monetization strategies
for Psychedelic Spotlight, in addition to exploring and identifying
any potential revenue-focused opportunities the Company is yet to
tap into.
Ms. Divine joins the PSYC Advisory Board as the proud
Founder of Black People
Trip. Launched in 2020, Black
People Trip is dedicated to education, advocacy for equity, and
creating safe spaces for the Black community, specifically Black
womxn. Moreover, Ms. Divine launched a Black Psychedelic Equity
Fund with the intent of helping those who need access to proper
care but lack the means to afford therapies and medicinal
psychedelics.
The Company will rely on Ms. Divine’s expertise and
passion to expand on Psychedelic Spotlight’s focus and commitment
to championing Diversity, Equity and Inclusion (“DEI”) within the
psychedelic community, as a trusted voice and leader for the space,
and internally for the Company.
Also joining the PSYC Advisory Board is Mr. Brad
Schlesinger, Esq. For over a decade, Brad worked as a criminal,
legal and drug policy researcher and then practicing attorney. As a
public defender with experience in criminal and appellate courts,
and a member of the United States Supreme Court Bar, Mr.
Schlesinger provides a unique insight into the legal system. He’s a
subject matter expert on systemic racism within the carceral state,
sentencing law and policy, drug policy, and civil
liberties.
“We are truly delighted and humbled to welcome each
of these incredibly talented and wonderful individuals to the PSYC
family,” said PSYC CEO, David Flores. “The passion, experience and
knowledge they each bring from their respective backgrounds is, in
my opinion, another example of the world class team we are
assembling for PSYC. Moreover, their dedication to inspiring
positive change throughout the psychedelic community and society
very much aligns with our Company’s commitment to direct action
while contributing to the advancement of our mission of building
substantial, tangible value for both PSYC’s loyal shareholders and
the communities we live in.”
About PSYC
Corporation (OTCPink:
PSYC)
At PSYC
Corporation we are integrating media, creativity, and technology to
develop and deploy thought-provoking ideas and solutions that are
fostering and transforming the approach to some of society’s most
pressing matters.
PSYC has
expressed its intent and commitment to positioning itself at the
forefront of the psychedelic revolution and as a resource center
for discovering and understanding the latest research and business
opportunities surrounding psychedelic inspired medicines. In
conjunction with the FDA’s more open-minded approach to psychedelic
medicines, and as several major U.S. cities continue to approve the
decriminalization of psilocybin, we believe investors are
speculating that the psychedelic boom could be bigger than that of
cannabis. PSYC is your source for current investment related news
specific to psychedelic medicines and cutting-edge research
improving overall health, moving this sector into the
mainstream.
We are
dedicated to a forward-thinking approach that embraces
groundbreaking new technology and innovations and through the
vision of business development we intend to continue to evolve into
these unchartered territories as the industry leaders of the
future.
Forward-Looking Statements Disclaimer:
This press
release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. In some
cases, you can identify forward-looking statements by the following
words: "anticipate," "believe," "continue," "could," "estimate,"
"expect," "intend," "may," "ongoing," "plan," "potential,"
"predict," "project," "should," "will," "would," or the negative of
these terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results and
will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainty and other factors, including the effect of
COVID-19 and the success of the current vaccine distribution, the
adverse effect of the Omicron variant, that may cause our results,
levels of activity, performance or achievements to be materially
different from the information expressed or implied by the
forward-looking statements in this press release. This press
release should be considered in light of all filings of the Company
that are disclosed on the OTC Markets.com website and is not
incorporated by reference into such
reports.
Disclaimer: PSYC Corporation does not in any way encourage or
condone the use, purchase, sale or transfer of any illegal
substances, nor do we encourage or condone partaking in any
unlawful activities. We support a harm reduction approach for the
purpose of education and promoting individual and public safety. If
you are choosing to use psychedelic substances, please do so
responsibly.
Corporate
Contact:
PSYC
Corporation (PSYC)
www.psyccorporation.com
(702)
239-1919
info@psyccorporation.com
OTCPINK:
PSYC
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Mar 2024 to Apr 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Apr 2023 to Apr 2024